Neuromuscular

Filter Your Results

 

News

 

Biosimilar Being Developed for Botox

Thursday, March 01, 2018—In a transatlantic collaboration, Mylan N.V. (Pittsburgh, Pennsylvania) and Revance Therapeutics, Inc. (Hertsfordshire, England) have reached an agreement to collaborate on th…

Microglia May Promote Recovery of Motor Neurons in Amyotrophic Lateral Sclerosis

Wednesday, February 21, 2018—In findings published this week in Nature Neuroscience, researchers Krista J. Spiller, Clark R. Restrepo, Tahiyana Khan, and others described creation of a mouse model of amyo…

Results from Phase 2 Trial of Stem-Cell Treatment for Amyotrophic Lateral Sclerosis to Be Presented at American Academy of Neurology 2018

Wednesday, February 07, 2018—Brainstorm Cell Therapeutics Inc. announced that they will present results from the NurOwn phase 2 randomized, double-blind, placebo-controlled study, showing ALSFRS-R subgrou…

Sublingual Formulation of Riluzole Bioequivalent to Tablet Formulation

Tuesday, January 09, 2018—Biohaven announced positive results from its bioequivalence study of BHV-0223, an innovative sublingual formulation of riluzole, currently available as a 50-mg tablet, which i…

Neuroimaging: Bolstering the Role of Neurologists

September 2017—“There is no question that neuroimaging is an extremely complex subject that requires subspecialty experience, an interest, and a focus in that area. To ask a general ra…

Tics and Tourette Syndrome

Joseph Jankovic, MD

September 2017—Recognizing the full spectrum of phenomenology of tics and various behavioral comorbidities is critical to diagnosis.

In-Focus: Parkinson’s Disease

April 2016—New Findings Clarify Cognitive Difficulties in Communication for PD patients The ability to keep up with conversations can be a challenge for some patients with Parkinson&r…

Posterior Reversible Encephalopathy Syndrome (PRES): A Case Report and Review of the Literature

Kevin G. Lazo, DO, Steven Mandel, MD, Bidyut Pramanik, MD, Jane Lee, MD, Maria V. Devita, MD, David Coven, MD, PhD, and Sandra Gelbard, MD

April 2016—Posterior Reversible Encephalopathy Syndrome (PRES) is a condition caused by reversible subcortical vasogenic edema that can clinically manifest with headache, altered mental …

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC